CS591884A2 - Zpusob vyroby piperidinochinazolinu - Google Patents

Zpusob vyroby piperidinochinazolinu

Info

Publication number
CS591884A2
CS591884A2 CS845918A CS591884A CS591884A2 CS 591884 A2 CS591884 A2 CS 591884A2 CS 845918 A CS845918 A CS 845918A CS 591884 A CS591884 A CS 591884A CS 591884 A2 CS591884 A2 CS 591884A2
Authority
CS
Czechoslovakia
Prior art keywords
piperidinochinazolinu
zpusob vyroby
vyroby
zpusob
vyroby piperidinochinazolinu
Prior art date
Application number
CS845918A
Other languages
English (en)
Other versions
CS253714B2 (en
Inventor
Simon Fraser Dr Campbell
David Anthony Dr Roberts
Chamiec Albert Andrzej Dr Jaxa
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS591884A2 publication Critical patent/CS591884A2/cs
Publication of CS253714B2 publication Critical patent/CS253714B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
CS845918A 1983-08-03 1984-08-03 Process for preparing piperidinoquinazolines CS253714B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320958A GB8320958D0 (en) 1983-08-03 1983-08-03 Quinazoline cardiac stimulants

Publications (2)

Publication Number Publication Date
CS591884A2 true CS591884A2 (en) 1987-05-14
CS253714B2 CS253714B2 (en) 1987-12-17

Family

ID=10546755

Family Applications (1)

Application Number Title Priority Date Filing Date
CS845918A CS253714B2 (en) 1983-08-03 1984-08-03 Process for preparing piperidinoquinazolines

Country Status (22)

Country Link
US (1) US4542132A (cs)
EP (1) EP0135318B1 (cs)
JP (1) JPS6069081A (cs)
KR (1) KR870000905B1 (cs)
AU (1) AU555482B2 (cs)
CS (1) CS253714B2 (cs)
DD (1) DD223452A5 (cs)
DE (1) DE3472677D1 (cs)
DK (1) DK375584A (cs)
ES (1) ES8507536A1 (cs)
FI (1) FI843047A7 (cs)
GB (1) GB8320958D0 (cs)
GR (1) GR82659B (cs)
HU (1) HUT37421A (cs)
IL (1) IL72562A (cs)
NO (1) NO158941C (cs)
NZ (1) NZ209095A (cs)
PH (1) PH20835A (cs)
PL (1) PL249025A1 (cs)
PT (1) PT79001B (cs)
YU (1) YU135884A (cs)
ZA (1) ZA845944B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
CA2148260A1 (en) * 1993-09-10 1995-03-16 Yasutaka Takase Quinazoline cpompounds
US7825244B2 (en) * 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
JP2009213594A (ja) * 2008-03-10 2009-09-24 Okamura Chikuzai:Kk 葬祭用祭壇装置
CN104860870A (zh) * 2014-02-26 2015-08-26 欧美嘉股份有限公司 具有不同取代基的哌啶的制备方法
US11242322B2 (en) * 2020-01-31 2022-02-08 Trinapco, Inc. Triflazoles and methods of making the same
US11294401B2 (en) 2020-07-08 2022-04-05 Saudi Arabian Oil Company Flow management systems and related methods for oil and gas applications
US11131158B1 (en) 2020-07-08 2021-09-28 Saudi Arabian Oil Company Flow management systems and related methods for oil and gas applications
US11314266B2 (en) 2020-07-08 2022-04-26 Saudi Arabian Oil Company Flow management systems and related methods for oil and gas applications
US11274501B2 (en) 2020-07-08 2022-03-15 Saudi Arabian Oil Company Flow management systems and related methods for oil and gas applications
US11256273B2 (en) 2020-07-08 2022-02-22 Saudi Arabian Oil Company Flow management systems and related methods for oil and gas applications
US11802645B2 (en) 2020-07-08 2023-10-31 Saudi Arabian Oil Company Flow management systems and related methods for oil and gas applications

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US4101548A (en) * 1977-02-22 1978-07-18 Bristol-Myers Company 1,2,3-Thiadiazole amides
IN148482B (cs) * 1977-06-03 1981-03-07 Pfizer
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants

Also Published As

Publication number Publication date
DE3472677D1 (de) 1988-08-18
JPS6069081A (ja) 1985-04-19
NO158941C (no) 1988-11-16
NO843117L (no) 1985-02-04
ZA845944B (en) 1986-07-30
FI843047A0 (fi) 1984-08-01
PT79001A (en) 1984-08-01
AU3141984A (en) 1985-02-07
DK375584A (da) 1985-02-04
DD223452A5 (de) 1985-06-12
IL72562A0 (en) 1984-11-30
DK375584D0 (da) 1984-08-02
IL72562A (en) 1987-03-31
AU555482B2 (en) 1986-09-25
NO158941B (no) 1988-08-08
ES534824A0 (es) 1985-09-01
GB8320958D0 (en) 1983-09-07
PH20835A (en) 1987-04-30
CS253714B2 (en) 1987-12-17
KR850001746A (ko) 1985-04-01
EP0135318B1 (en) 1988-07-13
PL249025A1 (en) 1985-08-27
ES8507536A1 (es) 1985-09-01
NZ209095A (en) 1986-11-12
FI843047A7 (fi) 1985-02-04
YU135884A (en) 1986-10-31
EP0135318A1 (en) 1985-03-27
GR82659B (cs) 1985-02-07
HUT37421A (en) 1985-12-28
PT79001B (en) 1986-10-23
US4542132A (en) 1985-09-17
KR870000905B1 (ko) 1987-05-04

Similar Documents

Publication Publication Date Title
AR242392A1 (es) Procedimiento para preparar derivados del acido 7beta-(carboxialquenoilamino)-(1-o,1-5 o 1-50)-3 cefem-4- carboxilico, y los intermediarios de aplicacion exclusiva en dicho procedimiento.
CS153784A2 (en) Zpusob vyroby aminomethylpyrrolidinonu
CS127684A2 (en) Zpusob vyroby derivatu triazolu
CS591884A2 (en) Zpusob vyroby piperidinochinazolinu
CS524985A2 (en) Zpusob vyroby novych kondenzovanych derivatu pyrrolu
CS187183A1 (en) Operna deska
CS208583A1 (en) Regulace otacek vetrneho motoru
CS116083A1 (en) Zaruvzdorna slitina
CS334583A1 (en) Vnejsi klika dveri motoroveho vozidla
CS312783A1 (en) Strihadlo tonkostennych ohybanych plechu
CS304583A1 (en) Setricky tranzistorovy impulzovaci kluc
CS299983A1 (en) Montazni lesenova plosina
CS277383A1 (en) Zapojeni tetrometru
CS264783A1 (en) Hydroretencni kompozice
CS261783A1 (en) Odpenovac
CS120683A1 (en) Odvzdusnovaci zarizeni
CS230384A2 (en) Fungicidni prostredek
CS222383A1 (en) Vykonova polovodicova soutastka rizena svetlem
CS357683A1 (en) Zpusob tepelneho zpracovani odstredive odlevanych odlitku
CS214384A2 (en) Zpusob pripravy mikrobialni bilkoviny
CS34383A1 (en) Zpusob destilace eterickych oleju
CS207083A1 (en) Zpusob pohybu snimace fyzikalnich velicin textilnich utvaru
CS202783A1 (en) Privod odstrediveho cerpadla
CS199883A1 (en) Tepelne izolujici okenni roleta
CS499783A1 (en) Divci kabela